MASIMO CORP (MASI) Fundamental Analysis & Valuation

NASDAQ:MASI • US5747951003

175.45 USD
+0.03 (+0.02%)
At close: Mar 9, 2026
175.21 USD
-0.24 (-0.14%)
After Hours: 3/9/2026, 8:18:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MASI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall MASI gets a fundamental rating of 5 out of 10. We evaluated MASI against 184 industry peers in the Health Care Equipment & Supplies industry. While MASI has a great health rating, its profitability is only average at the moment. MASI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. MASI Profitability Analysis

1.1 Basic Checks

  • MASI had positive earnings in the past year.
  • In the past year MASI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: MASI reported negative net income in multiple years.
  • MASI had a positive operating cash flow in each of the past 5 years.
MASI Yearly Net Income VS EBIT VS OCF VS FCFMASI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • With a decent Return On Assets value of -8.92%, MASI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • MASI has a Return On Equity (-21.01%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 17.73%, MASI belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MASI is in line with the industry average of 9.15%.
  • The last Return On Invested Capital (17.73%) for MASI is above the 3 year average (8.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.92%
ROE -21.01%
ROIC 17.73%
ROA(3y)-5.95%
ROA(5y)-0.24%
ROE(3y)-14.67%
ROE(5y)-3.7%
ROIC(3y)8.57%
ROIC(5y)9.02%
MASI Yearly ROA, ROE, ROICMASI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • MASI has a Operating Margin of 20.49%. This is amongst the best in the industry. MASI outperforms 92.93% of its industry peers.
  • MASI's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 61.90%, MASI is doing good in the industry, outperforming 64.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MASI has remained more or less at the same level.
Industry RankSector Rank
OM 20.49%
PM (TTM) N/A
GM 61.9%
OM growth 3Y22.55%
OM growth 5Y-1.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.98%
GM growth 5Y-0.96%
MASI Yearly Profit, Operating, Gross MarginsMASI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. MASI Health Analysis

2.1 Basic Checks

  • MASI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for MASI has been reduced compared to 1 year ago.
  • MASI has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MASI has a worse debt to assets ratio.
MASI Yearly Shares OutstandingMASI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MASI Yearly Total Debt VS Total AssetsMASI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MASI has an Altman-Z score of 8.62. This indicates that MASI is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.62, MASI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • MASI has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as MASI would need 2.72 years to pay back of all of its debts.
  • MASI has a better Debt to FCF ratio (2.72) than 83.15% of its industry peers.
  • MASI has a Debt/Equity ratio of 0.72. This is a neutral value indicating MASI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.72, MASI is doing worse than 68.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 2.72
Altman-Z 8.62
ROIC/WACC1.81
WACC9.78%
MASI Yearly LT Debt VS Equity VS FCFMASI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.49 indicates that MASI has no problem at all paying its short term obligations.
  • MASI's Current ratio of 2.49 is in line compared to the rest of the industry. MASI outperforms 50.00% of its industry peers.
  • MASI has a Quick Ratio of 1.47. This is a normal value and indicates that MASI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.47, MASI perfoms like the industry average, outperforming 40.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.47
MASI Yearly Current Assets VS Current LiabilitesMASI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MASI Growth Analysis

3.1 Past

  • MASI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.59%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 5.86% on average over the past years.
  • The Revenue for MASI has decreased by -27.10% in the past year. This is quite bad
  • Measured over the past years, MASI shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)34.59%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%120.08%
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y4.03%
Revenue growth 5Y8.27%
Sales Q2Q%-31.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.11% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -1.10% on average over the next years.
EPS Next Y31.03%
EPS Next 2Y18.54%
EPS Next 3Y16.39%
EPS Next 5Y12.11%
Revenue Next Year-27.07%
Revenue Next 2Y-11.73%
Revenue Next 3Y-5.71%
Revenue Next 5Y-1.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MASI Yearly Revenue VS EstimatesMASI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
MASI Yearly EPS VS EstimatesMASI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. MASI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.99, MASI can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, MASI is valued a bit cheaper than 70.11% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of MASI to the average of the S&P500 Index (26.45), we can say MASI is valued expensively.
  • The Price/Forward Earnings ratio is 29.17, which means the current valuation is very expensive for MASI.
  • 71.74% of the companies in the same industry are more expensive than MASI, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.65, MASI is valued at the same level.
Industry RankSector Rank
PE 40.99
Fwd PE 29.17
MASI Price Earnings VS Forward Price EarningsMASI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 70.11% of the companies in the same industry are more expensive than MASI, based on the Enterprise Value to EBITDA ratio.
  • 73.37% of the companies in the same industry are more expensive than MASI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 47.43
EV/EBITDA 27.11
MASI Per share dataMASI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of MASI may justify a higher PE ratio.
  • A more expensive valuation may be justified as MASI's earnings are expected to grow with 16.39% in the coming years.
PEG (NY)1.32
PEG (5Y)7
EPS Next 2Y18.54%
EPS Next 3Y16.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MASI Dividend Analysis

5.1 Amount

  • No dividends for MASI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MASI Fundamentals: All Metrics, Ratios and Statistics

MASIMO CORP

NASDAQ:MASI (3/9/2026, 8:18:43 PM)

After market: 175.21 -0.24 (-0.14%)

175.45

+0.03 (+0.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners108.09%
Inst Owner Change-2.13%
Ins Owners0.21%
Ins Owner Change3.06%
Market Cap9.16B
Revenue(TTM)1.53B
Net Income(TTM)-151.50M
Analysts72
Price Target180.21 (2.71%)
Short Float %8.07%
Short Ratio2.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.35%
Max Revenue beat(4)-0.77%
Revenue beat(8)0
Avg Revenue beat(8)-1.05%
Revenue beat(12)0
Avg Revenue beat(12)-1.92%
Revenue beat(16)3
Avg Revenue beat(16)-1.31%
PT rev (1m)-3.73%
PT rev (3m)-3.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.26%
EPS NY rev (1m)0%
EPS NY rev (3m)0.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 40.99
Fwd PE 29.17
P/S 6
P/FCF 47.43
P/OCF 42.05
P/B 12.7
P/tB 16.12
EV/EBITDA 27.11
EPS(TTM)4.28
EY2.44%
EPS(NY)6.01
Fwd EY3.43%
FCF(TTM)3.7
FCFY2.11%
OCF(TTM)4.17
OCFY2.38%
SpS29.25
BVpS13.82
TBVpS10.88
PEG (NY)1.32
PEG (5Y)7
Graham Number36.48
Profitability
Industry RankSector Rank
ROA -8.92%
ROE -21.01%
ROCE 23.57%
ROIC 17.73%
ROICexc 20.03%
ROICexgc 23.03%
OM 20.49%
PM (TTM) N/A
GM 61.9%
FCFM 12.65%
ROA(3y)-5.95%
ROA(5y)-0.24%
ROE(3y)-14.67%
ROE(5y)-3.7%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)9.54%
ROICexc(5y)11.91%
ROICexgc(3y)12.71%
ROICexgc(5y)16.36%
ROCE(3y)11.38%
ROCE(5y)11.99%
ROICexgc growth 3Y17.79%
ROICexgc growth 5Y-4.56%
ROICexc growth 3Y40.83%
ROICexc growth 5Y-2.68%
OM growth 3Y22.55%
OM growth 5Y-1.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.98%
GM growth 5Y-0.96%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 2.72
Debt/EBITDA 1.47
Cap/Depr 63.66%
Cap/Sales 1.62%
Interest Coverage 9.54
Cash Conversion 61.95%
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 1.47
Altman-Z 8.62
F-Score7
WACC9.78%
ROIC/WACC1.81
Cap/Depr(3y)67.5%
Cap/Depr(5y)68.38%
Cap/Sales(3y)4.05%
Cap/Sales(5y)3.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.59%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%120.08%
EPS Next Y31.03%
EPS Next 2Y18.54%
EPS Next 3Y16.39%
EPS Next 5Y12.11%
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y4.03%
Revenue growth 5Y8.27%
Sales Q2Q%-31.33%
Revenue Next Year-27.07%
Revenue Next 2Y-11.73%
Revenue Next 3Y-5.71%
Revenue Next 5Y-1.1%
EBIT growth 1Y614.16%
EBIT growth 3Y11.34%
EBIT growth 5Y4.15%
EBIT Next Year19.19%
EBIT Next 3Y9.47%
EBIT Next 5Y9.31%
FCF growth 1Y32.9%
FCF growth 3YN/A
FCF growth 5Y8.07%
OCF growth 1Y10.9%
OCF growth 3Y94.94%
OCF growth 5Y0.64%

MASIMO CORP / MASI FAQ

What is the fundamental rating for MASI stock?

ChartMill assigns a fundamental rating of 5 / 10 to MASI.


Can you provide the valuation status for MASIMO CORP?

ChartMill assigns a valuation rating of 4 / 10 to MASIMO CORP (MASI). This can be considered as Fairly Valued.


Can you provide the profitability details for MASIMO CORP?

MASIMO CORP (MASI) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MASI stock?

The Price/Earnings (PE) ratio for MASIMO CORP (MASI) is 40.99 and the Price/Book (PB) ratio is 12.7.


Can you provide the financial health for MASI stock?

The financial health rating of MASIMO CORP (MASI) is 7 / 10.